Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Reshuffle in a $27 Billion Market
Motley Fool
Sunday, September 29, 2013 - 1:48pm
tags:
COPD, Breo Ellipta, Theravance, GSK
Can Drug-Stock Dividends Last?
Motley Fool
Sunday, September 29, 2013 - 1:47pm
tags:
Time to Panic About Merck's Patent Expirations?
Motley Fool
Sunday, September 29, 2013 - 1:47pm
tags:
Merck, patents
2 Are Better Than 1: Endocyte Uses Diagnostics To Complements Its Drugs
Seeking Alpha
Sunday, September 29, 2013 - 1:41pm
tags:
Endocyte, diagnostics, EC145, ovarian cancer
Meet the 2 Newest Investments in Cystic Fibrosis
Motley Fool
Sunday, September 29, 2013 - 1:37pm
tags:
cystic fibrosis, Kalydeco, Roche, Vertex Pharmaceuticals
Twitter Trounces Wall St. With Real-Time Take on Achillion Pharma's Hep C News
The Street
Sunday, September 29, 2013 - 1:36pm
tags:
twitter, Achillion, hepatitis C
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sunday, September 29, 2013 - 1:35pm
tags:
TSR-011, pancreatic cancer, Tesaro
2 More Bold Speculative Biotech Plays
Seeking Alpha
Sunday, September 29, 2013 - 1:34pm
tags:
Geron, Navidea Biopharmaceuticals
BioMarin Provides Updated Phase 1/2 Data on BMN 673 in Breast Cancer at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sunday, September 29, 2013 - 1:33pm
tags:
BMN 673, breast cancer, Biomarin
OncoMed Pharmaceuticals Presents Updated Phase 1a Data in Advanced Solid Tumor Patients for the First-in-Class WNT-Pathway-Targeting Antibody Vantictumab (OMP-18R5) at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sunday, September 29, 2013 - 1:32pm
tags:
vantictumab, OMP-18R5, neuroendocrine tumors, OncoMed, solid tumors
Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule
Yahoo/BusinessWire
Sunday, September 29, 2013 - 1:30pm
tags:
Clovis Oncology, ovarian cancer, rucaparib, solid tumors
Insiders Are Selling Gilead Sciences
Seeking Alpha
Sunday, September 29, 2013 - 1:29pm
tags:
Gilead Sciences
China Biotech In Review: Amgen Partners With ShanghaiTech On China R&D Center
Seeking Alpha
Sunday, September 29, 2013 - 1:29pm
tags:
Mindray, JHL Biotech, Amgen, Sinochem Jiangsu Pharma, Boehringer Ingelheim
Will Galena's Initiatives Translate Into Positive Returns?
Seeking Alpha
Sunday, September 29, 2013 - 1:27pm
tags:
Galena Biopharma
Celldex Stock's Premature Jump Leads Biotech's Weekly Gains
Motley Fool
Sunday, September 29, 2013 - 1:25pm
tags:
Celldex
House Passes Bill That Would Add Scrutiny to Drug Makers
Bloomberg
Sunday, September 29, 2013 - 1:24pm
tags:
FDA
Dendreon: Looking For Spare Change In The Cushions
Seeking Alpha
Sunday, September 29, 2013 - 1:23pm
tags:
Dendreon
3 Companies That Could Make You a Successful Clinical-Stage Biotech Investor
Motley Fool
Sunday, September 29, 2013 - 1:23pm
tags:
Gilead Sciences, Isis Pharmaceuticals, Nektar
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Saturday, September 28, 2013 - 1:09pm
tags:
biotech, Perrigo, Bristol-Myers Squibb, Elan, Clovis Oncology, IPOs, Stemline, Amgen, Biogen Idec, ONYX Pharmaceuticals
U.S. removes roadblock to Actavis-Warner Chilcott deal
Reuters
Saturday, September 28, 2013 - 12:28pm
tags:
Warner Chilcott, M&A, Actavis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.